ArticleWorld journal of urology2025
Utility of node-RADS in preoperatively detecting pelvic lymph node metastasis in bladder cancer.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integration of Node-RADS and Habitat Radiomics for Predicting Occult Nodal Metastasis in Bladder Cancer.Annals of surgical oncology · 2026Article
- Node-RADS in cervical cancer: a multi-reader agreement and diagnostic performance study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- A head-to-head comparison of MRI and CT using Node-RADS for rectal cancer lymph nodes: Observer agreement and diagnostic performance.European journal of radiology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAn accurate preoperative nodal staging is crucial for muscle-invasive bladder cancer in risk stratification and treatment decision-making. However, conventional cross-sectional imaging cannot replace pelvic lymph node dissection (PLND) due to accuracy concerns. Recently, Node Reporting and Data System (Node-RADS), a novel structured reporting system for oncological nodal evaluation, has been recently launched. The study is designed to explore the diagnostic utility of Node-RADS in clinical management compared with PLND in bladder cancer.
methodsThe study retrospectively collected patients diagnosed with bladder cancer who had received a preoperative computed tomography scan and subsequent radical cystectomy. Two radiologists independently reviewed the scans according to Node-RADS 1.0 criteria. Nodal staging was histopathologically confirmed by surgical specimens from PLND. The diagnostic performance of Node-RADS was compared both at patient and regional levels. Cohen's kappa was used to exhibit interreader agreement.
resultsLymph node metastasis was found in 22/85 patients by standard PLND. Both Node-RADS score>3 and 4 were suitable diagnostic cutoffs. Node-RADS scores highly correlated with the results of PLND. It exhibited promising diagnostic performance with moderate sensitivity (55.00%), high specificity (85.48%), accuracy (78.05%), and excellent interreader agreement (kappa 0.73-0.95). Whereas, Node-RADS was not observed to have obviously superior diagnostic performance to nodal size criteria in our cohort.
conclusionThe study supported the utility of Node-RADS in preoperative pelvic nodal staging, which may assist urologists in selecting appropriate nodal templates. A high positive predictive value enabled the early identification of suitable patients for multimodal treatment to achieve optimal oncological outcomes.
Indexed as
Identifiers
41212322What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.